T. Shaw3, L., I. Hariprasad, L. V. Messner, C. A. Bansal, S. A. Schechet, and J. Pérez. “Topical Nepafenac 0.1% or 0.3% for the Treatment of Central Serous Chorioretinopathy: A Case Series of Chronic and Recurrent Disease and Review of the Literature”. BOHR International Journal of Current Research in Optometry and Ophthalmology, vol. 1, no. 1, Oct. 2022, pp. 74–79, doi:10.54646/bijcroo.2022.19.